United States · 
Who invested in Elixir Pharmaceuticals?
Elixir Pharmaceuticals's investors include ARCH Venture Partners, MPM Capital, Oxford Bioscience Partners, Icon Ventures and Jafco Ventures, and 5 more on record.
200720082009
$46MSeries C$12MSeries DUnited States · Series D startup
Who invested in Elixir Pharmaceuticals
2 rounds we have observed, with the 10 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$58Mraised across 2 rounds since 2006, from 2 sources
$46MSeries C$12MSeries D
- Latest round
- Series D, $12MMay 2009
- Biggest round
- $46MSeries C · Nov 2006
- Investors
- 10
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series C, $46M Nov 2006
- Biggest round
- $46M Series C · Nov 2006
- Between rounds
- 2.5 years from the last two
The rounds
- May 2009Series D$12M2 new3 returning
Reported by onbiovc.comSEC filing: $12M sold, first sale May 2009
- Nov 2006
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Oxford Bioscience PartnersGrowth equity2rounds
Jafco VenturesGrowth equity1round
Hercules Technology Growth CapitalInvestment firm1round
CDIB BioScience VenturesGrowth equity1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Elixir Pharmaceuticals
How much has Elixir Pharmaceuticals raised?
Elixir Pharmaceuticals has raised $58M across 2 rounds since 2006.
When did Elixir Pharmaceuticals last raise?
Elixir Pharmaceuticals's most recent round was a Series D of $12M in May 2009.
What was Elixir Pharmaceuticals's biggest round?
Elixir Pharmaceuticals's largest round on record is $46M (Series C), in Nov 2006.
Who backed Elixir Pharmaceuticals first?
Elixir Pharmaceuticals's first round on record, in Nov 2006, was backed by ARCH Venture Partners, Icon Ventures and MPM Capital and 5 others.
What stage is Elixir Pharmaceuticals at?
Elixir Pharmaceuticals's latest named round is a Series D, in May 2009.
Where is Elixir Pharmaceuticals based?
Elixir Pharmaceuticals is based in the United States.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.